Stockreport

enGene Reports First Quarter 2025 Financial Results and Provides Business Update

enGene Holdings Inc.  (ENGN) 
PDF Additional preliminary data from ongoing LEGEND study of detalimogene in BCG-unresponsive NMIBC with CIS, including pivotal cohort, anticipated in 2H 2025Biologics Licen [Read more]